Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Analysis of gene expression in two large schizophrenia cohorts identifies multiple changes associated with nerve terminal function

A Corrigendum to this article was published on 24 March 2010

A Corrigendum to this article was published on 18 November 2009

Abstract

Schizophrenia is a severe psychiatric disorder with a world-wide prevalence of 1%. The pathophysiology of the illness is not understood, but is thought to have a strong genetic component with some environmental influences on aetiology. To gain further insight into disease mechanism, we used microarray technology to determine the expression of over 30 000 mRNA transcripts in post-mortem tissue from a brain region associated with the pathophysiology of the disease (Brodmann area 10: anterior prefrontal cortex) in 28 schizophrenic and 23 control patients. We then compared our study (Charing Cross Hospital prospective collection) with that of an independent prefrontal cortex dataset from the Harvard Brain Bank. We report the first direct comparison between two independent studies. A total of 51 gene expression changes have been identified that are common between the schizophrenia cohorts, and 49 show the same direction of disease-associated regulation. In particular, changes were observed in gene sets associated with synaptic vesicle recycling, transmitter release and cytoskeletal dynamics. This strongly suggests multiple, small but synergistic changes in gene expression that affect nerve terminal function.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  1. Cardno AG, Marshall EJ, Coid B, Macdonald AM, Ribchester TR . Heritability estimates for psychotic disorders: the Maudsley twin psychosis series. Arch Gen Psychiatry 1999; 56: 162–168.

    Article  CAS  PubMed  Google Scholar 

  2. Sullivan PF . Schizophrenia genetics: the search for a hard lead. Curr Opin Psychiatry 2008; 21: 157–160.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Ross CA, Margolis RL, Reading SA, Pletnikov M, Coyle JT . Neurobiology of schizophrenia. Neuron 2006; 52: 139–153.

    Article  CAS  PubMed  Google Scholar 

  4. Pongrac J, Middleton FA, Lewis DA, Levitt P, Mirnics K . Gene expression profiling with DNA microarrays: advancing our understanding of psychiatric disorders. Neurochem Res 2002; 27: 1049–1063.

    Article  CAS  PubMed  Google Scholar 

  5. Konradi C . Gene expression microarray studies in polygenic psychiatric disorders: applications and data analysis. Brain Res Rev 2005; 50: 142–155.

    Article  CAS  PubMed  Google Scholar 

  6. Sequeira A, Turecki G . Genome wide gene expression studies in mood disorders. OMICS 2006; 10: 444–454.

    Article  CAS  PubMed  Google Scholar 

  7. Mirnics K, Middleton FA, Marquez A, Lewis DA, Levitt P . Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex. Neuron 2000; 28: 53–67.

    Article  CAS  PubMed  Google Scholar 

  8. Vawter MP, Crook JM, Hyde TM, Kleinman JE, Weinberger DR, Becker KG et al. Microarray analysis of gene expression in the prefrontal cortex in schizophrenia: a preliminary study. Schizophr Res 2002; 58: 11–20.

    Article  PubMed  Google Scholar 

  9. Middleton FA, Mirnics K, Pierri JN, Lewis DA, Levitt P . Gene expression profiling reveals alterations of specific metabolic pathways in schizophrenia. J Neurosci 2002; 22: 2718–2729.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Prabakaran S, Swatton JE, Ryan MM, Huffaker SJ, Huang JT, Griffin JL et al. Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress. Mol Psychiatry 2004; 9: 684–697.

    Article  CAS  PubMed  Google Scholar 

  11. Tkachev D, Mimmack ML, Ryan MM, Wayland M, Freeman T, Jones PB et al. Oligodendrocyte dysfunction in schizophrenia and bipolar disorder. Lancet 2003; 362: 798–805.

    Article  CAS  PubMed  Google Scholar 

  12. McCullumsmith R, Gupta D, Beneyto M, Kreger E, Haroutunian V, Davis KL et al. Expression of transcripts for myelination-related genes in the anterior cingulate cortex in schizophrenia. Schizophr Res 2004; 90: 15–27.

    Article  Google Scholar 

  13. Hakak Y, Walker JR, Li C, Wong WH, Davis KL, Buxbaum JD et al. Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proc Natl Acad Sci USA 2001; 98: 4746–4751.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Mitkus SN, Hyde TM, Vakkalanka R, Kolachana B, Weinberger DR, Kleinman JE et al. Expression of oligodendrocyte-associated genes in dorsolateral prefrontal cortex of patients with schizophrenia. Schizophr Res 2008; 98: 129–138.

    Article  PubMed  Google Scholar 

  15. Arion D, Unger T, Lewis DA, Levitt P, Mirnics K . Molecular evidence for increased expression of genes related to immune and chaperone function in the prefrontal cortex in schizophrenia. Biol Psychiatry 2007; 62: 711–721.

    CAS  PubMed  PubMed Central  Google Scholar 

  16. Saetre P, Emilsson L, Axelsson E, Kreuger J, Lindholm E, Jazin E . Inflammation-related genes up-regulated in schizophrenia brains. BMC Psychiatry 2007; 7: 46.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Miklos GLG, Maleszka R . Microarray reality checks in the context of a complex disease. Nat Biotechnol 2004; 22: 615–621.

    Article  CAS  PubMed  Google Scholar 

  18. Glatt SJ, Everall IP, Kremen WS, Corbeil J, Sásik R, Khanlou N et al. Comparative gene expression analysis of blood and brain provides concurrent validation of SELENBP1 up-regulation in schizophrenia. Proc Natl Acad Sci USA 2005; 102: 15533–15538.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. MacDonald AW, Carter CS, Kerns JG, Ursu S, Barch DM, Holmes AJ et al. Specificity of prefrontal dysfunction and context processing deficits to schizophrenia in never-medicated patients with first-episode psychosis. Am J Psychiatry 2005; 162: 475–484.

    Article  PubMed  Google Scholar 

  20. Yoon JH . Association of dorsolateral prefrontal cortex dysfunction with disrupted coordinated brain activity in schizophrenia: relationship with impaired cognition, behavioral disorganization, and global function. Am J Psychiatry 2008; 165: 1006–1014.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Bustin S . Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays. J Mol Endocrinol 2000; 25: 169–193.

    Article  CAS  PubMed  Google Scholar 

  22. Weng L, Dai H, Zhan Y, He Y, Stepaniants SB, Bassett DE . Rosetta error model for gene expression analysis. Bioinformatics 2006; 22: 1111–1121.

    Article  CAS  PubMed  Google Scholar 

  23. Bond BC, Virley DJ, Cairns NJ, Hunter AJ, Moore GB, Moss SJ et al. The quantification of gene expression in an animal model of brain ischaemia using TaqMan real-time RT-PCR. Brain Res Mol Brain Res 2002; 106: 101–116.

    Article  CAS  PubMed  Google Scholar 

  24. Mootha VK, Lindgren CM, Eriksson KF, Subramanian A, Sihag S, Lehar J et al. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 2003; 34: 267–273.

    Article  CAS  PubMed  Google Scholar 

  25. Kim SY, Volsky DJ . PAGE: parametric analysis of gene set enrichment. BMC Bioinformatics 2005; 6: 144.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Emes RD, Pocklington AJ, Anderson CN, Bayes A, Collins MO, Vickers CA et al. Evolutionary expansion and anatomical specialization of synapse proteome complexity. Nat Neurosci 2008; 7: 799–806.

    Article  Google Scholar 

  27. Lipska BK, Deep-Soboslay A, Weickert CS, Hyde TM, Martin CE, Herman MM et al. Critical factors in gene expression in postmortem human brain: focus on studies in schizophrenia. Biol Psychiatry 2006; 60: 650–658.

    Article  CAS  PubMed  Google Scholar 

  28. Vawter MP, Tomita H, Meng F, Bolstad B, Li J, Evans S et al. Mitochondrial-related gene expression changes are sensitive to agonal-pH state: implications for brain disorders. Mol Psychiatry 2006; 11: 663–679.

    Article  CAS  Google Scholar 

  29. Tomita H, Vawter MP, Walsh DM, Evans SJ, Choudary PV, Li J et al. Effect of agonal and postmortem factors on gene expression profile: quality control in microarray analyses of postmortem human brain. Biol Psychiatry 2004; 55: 346–352.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Camargo LM, Collura V, Rain JC, Mizuguchi K, Hermjakob H, Kerrien S et al. Disrupted in Schizophrenia 1 Interactome: evidence for the close connectivity of risk genes and a potential synaptic basis for schizophrenia. Mol Psychiatry 2007; 12: 74–86.

    Article  CAS  PubMed  Google Scholar 

  31. Guo AY, Sun J, Riley BP, Thiselton DL, Kendler KS, Zhao Z . The dystrobrevin-binding protein 1 gene: features and networks. Mol Psychiatry 2009; 14: 18–29.

    Article  CAS  PubMed  Google Scholar 

  32. Mexal S, Frank M, Berger R, Adams CE, Ross RG, Freedman R et al. Differential modulation of gene expression in the NMDA postsynaptic density of schizophrenic and control smokers. Mol Brain Res 2005; 139: 317–332.

    Article  CAS  PubMed  Google Scholar 

  33. Südhof TC . The synaptic vesicle cycle. Ann Rev Neurosci 2004; 27: 509–547.

    Article  PubMed  Google Scholar 

  34. Rizo J, Rosenmund C . Synaptic vesicle fusion. Nat Struct Mol Biol 2008; 15: 665–674.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Craxton M, Goedert M . Synaptotagmin V: a novel synaptotagmin isoform expressed in rat brain. FEBS Lett 1995; 36: 196–200.

    Article  Google Scholar 

  36. Paoletti P, Vergnano AM, Barbour B, Casado M . Zinc at glutamatergic synapses. Neuroscience 2009; 158: 126–136.

    Article  CAS  PubMed  Google Scholar 

  37. Wenzel HJ, Cole TB, Born DE, Schwartzkroin PA, Palmiter RD . Ultrastructural localization of zinc transporter-3 (ZnT-3) to synaptic vesicle membranes within mossy fiber boutons in the hippocampus of mouse and monkey. Proc Natl Acad Sci USA 1997; 94: 12676–12681.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Cole TB, Wenzel HJ, Kafer KE, Schwartzkroin PA, Palmiter RD . Elimination of zinc from synaptic vesicles in the intact mouse brain by disruption of the ZnT3 gene. Proc Natl Acad Sci USA 1999; 96: 1716–1721.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Cole TB, Martyanova A, Palmiter RD . Removing zinc from synaptic vesicles does not impair spatial learning, memory, or sensorimotor functions in the mouse. Brain Res 2001; 891: 253–256.

    Article  CAS  PubMed  Google Scholar 

  40. Frederickson CJ, Koh JY, Bush AI . The neurobiology of zinc in health and disease. Nat Rev Neurosci 2005; 6: 449–462.

    Article  CAS  PubMed  Google Scholar 

  41. Salazar G, Craige B, Love R, Kalman D, Faundez V . Vglut1 and ZnT3 co-targeting mechanisms regulate vesicular zinc stores in PC12 cells. J Cell Sci 2005; 118: 1911–1921.

    Article  CAS  PubMed  Google Scholar 

  42. Talbot K, Eidem WL, Tinsley CL, Benson MA, Thompson EW, Smith RJ et al. Dysbindin-1 is reduced in intrinsic, glutamatergic terminals of the hippocampal formation in schizophrenia. J Clin Invest 2004; 113: 1353–1363.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Stone JM, Morrison PD, Pilowsky LS . Glutamate and dopamine dysregulation in schizophrenia—a synthesis and selective review. J Psychopharmacol 2007; 21: 440–452.

    Article  CAS  PubMed  Google Scholar 

  44. Mochida S, Orita S, Sakaguchi G, Sasaki T, Takai Y . Role of the Doc2 alpha-Munc13-1 interaction in the neurotransmitter release process. Proc Natl Acad Sci USA 1998; 95: 11418–11422.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Oh E, Heise CJ, English JM, Cobb MH, Thurmond DC . WNK1 is a novel regulator of Munc18c-syntaxin 4 complex formation in soluble NSF attachment protein receptor (SNARE)-mediated vesicle exocytosis. J Biol Chem 2007; 282: 32613–32622.

    Article  CAS  PubMed  Google Scholar 

  46. Weirich CS, Erzberger JP, Barral Y . The septin family of GTPases: architecture and dynamics. Nat Rev Mol Cell Biol 2008; 9: 478–489.

    Article  CAS  PubMed  Google Scholar 

  47. Bidaud I, Mezghrani A, Swayne LA, Monteil A, Lory P . Voltage-gated calcium channels in genetic diseases. Biochim Biophys Acta 2006; 1763: 1169–1174.

    Article  CAS  PubMed  Google Scholar 

  48. Basu S, Pathak SK, Chatterjee G, Pathak S, Basu J, Kundu M . The neurotransmitter dopamine inhibits angiogenesis induced by vascular permeability factor/vascular endothelial growth factor. Nat Med 2001; 7: 569–574.

    Article  CAS  PubMed  Google Scholar 

  49. Teunis MA, Kavelaars A, Voest E, Bakker JM, Ellenbroek BA, Cools AR et al. Reduced tumor growth, experimental metastasis formation, and angiogenesis in rats with a hyperreactive dopaminergic system. FASEB J 2002; 16: 1465–1467.

    Article  CAS  PubMed  Google Scholar 

  50. Cingolani LA, Goda Y . Actin in action: the interplay between the actin cytoskeleton and synaptic efficacy. Nat Rev Neurosci 2008; 9: 344–356.

    Article  CAS  PubMed  Google Scholar 

  51. Kim Y, Sung JY, Ceglia I, Lee KW, Ahn JH, Halford JM . Phosphorylation of WAVE1 regulates actin polymerization and dendritic spine morphology. Nature 2006; 442: 814–817.

    Article  CAS  PubMed  Google Scholar 

  52. Owen MJ, O'Donovan MC, Harrison PJ . Schizophrenia: a genetic disorder of the synapse? BMJ 2005; 330: 158–159.

    Article  PubMed  PubMed Central  Google Scholar 

  53. Harrison PJ, Weinberger DR . Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol Psychiatry 2005; 10: 40–68.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We acknowledge the Harvard Brain Bank for depositing the raw data files for the McLean 66 cohort into the public domain. This study could not have undertaken without access to these data. TA and CA were supported by a research grant from GlaxoSmithKline.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to J de Belleroche.

Additional information

Supplementary Information accompanies the paper on the Molecular Psychiatry website (http://www.nature.com/mp)

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Maycox, P., Kelly, F., Taylor, A. et al. Analysis of gene expression in two large schizophrenia cohorts identifies multiple changes associated with nerve terminal function. Mol Psychiatry 14, 1083–1094 (2009). https://doi.org/10.1038/mp.2009.18

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/mp.2009.18

Keywords

This article is cited by

Search

Quick links